title: Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.
authors.forename: M
authors.initials: M
authors.lastname: Pérez-Olmeda
authors.forename: J
authors.initials: J
authors.lastname: González
authors.forename: J
authors.initials: J
authors.lastname: García-Samaniego
authors.forename: J R
authors.initials: JR
authors.lastname: Arribas
authors.forename: J M
authors.initials: JM
authors.lastname: Peña
authors.forename: V
authors.initials: V
authors.lastname: Soriano
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010865:Pilot Projects; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin